Valuation: Allurion Technologies Inc.

Capitalization 22.07M 18.91M 17.6M 16.4M 30.23M 1.89B 33.74M 214M 80.42M 888M 82.8M 81.09M 3.25B P/E ratio 2025 *
-3.18x
P/E ratio 2026 * -1.14x
Enterprise value 22.07M 18.91M 17.6M 16.4M 30.23M 1.89B 33.74M 214M 80.42M 888M 82.8M 81.09M 3.25B EV / Sales 2025 *
0.76x
EV / Sales 2026 * 0.51x
Free-Float
2.24%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.68%
1 week+0.33%
Current month+23.46%
1 month+17.65%
3 months+28.21%
6 months+2.39%
Current year-72.09%
More quotes
1 week 2.77
Extreme 2.7736
3.18
1 month 2.3
Extreme 2.3
3.18
Current year 2.15
Extreme 2.15
16.81
1 year 2.15
Extreme 2.15
23.5
3 years 2.15
Extreme 2.15
225
5 years 2.15
Extreme 2.15
225
10 years 2.15
Extreme 2.15
225
More quotes
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 65 31/10/2017
Chief Executive Officer 38 31/08/2009
Chief Operating Officer 52 02/06/2024
Director TitleAgeSince
Director/Board Member 38 31/08/2009
Chairman 69 31/07/2023
Director/Board Member 38 31/12/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.35%+0.33%-87.18%-98.27% 22.07M
+1.23%+2.07%+15.41%+101.33% 3,758B
+1.35%+7.56%+443.13%+1,597.36% 356B
+1.30%+9.14%+134.15%+135.47% 95.49B
+1.26%+2.09%+1.34%+86.19% 88.63B
+1.27%-1.49%+10.32%+104.99% 85.89B
+1.72%+15.33%+202.84%+204.74% 80.73B
+2.07%-2.77%+8.71%+3.48% 49.99B
+1.70%+0.25%-5.79%-16.08% 48.52B
-1.49%+0.09%+57.16%+90.49% 43.66B
Average +1.11%+1.29%+78.01%+220.97% 460.71B
Weighted average by Cap. +1.26%+0.95%+53.95%+216.87%
See all sector performances

Financials

2025 *2026 *
Net sales 28.98M 24.82M 23.1M 21.53M 39.68M 2.49B 44.28M 280M 106M 1.17B 109M 106M 4.27B 43.28M 37.07M 34.5M 32.16M 59.27M 3.71B 66.14M 419M 158M 1.74B 162M 159M 6.38B
Net income -5.2M -4.45M -4.15M -3.86M -7.12M -446M -7.95M -50.3M -18.94M -209M -19.5M -19.1M -766M -14.4M -12.34M -11.48M -10.7M -19.72M -1.24B -22.01M -139M -52.46M -580M -54.01M -52.9M -2.12B
Net Debt - -
More financial data * Estimated data
Logo Allurion Technologies Inc.
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.
Employees
136
More about the company
Date Price Change Volume
17/07/25 3.000 $ +1.35% 18,888
16/07/25 2.960 $ -6.92% 95,476
15/07/25 3.180 $ +11.19% 193,751
14/07/25 2.860 $ +0.70% 104,550
11/07/25 2.840 $ -5.02% 179,939

Delayed Quote Nyse, July 17, 2025 at 04:04 pm

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.960USD
Average target price
10.62USD
Spread / Average Target
+258.95%
Consensus

Quarterly revenue - Rate of surprise